News ArchivesRead News
Parkinson's event at Buck draws hundreds
Thursday September 17, 2009
Contra Costa Times - Researchers told more than 250 people packed into an auditorium at the Buck Institute for Age Research on Thursday that diagnosing and treating Parkinson's disease before people display symptoms has become one of the latest movements in the scientific field.
"The Holy Grail right now is the pre-symptomatic diagnosis and treatment of Parkinson's," Buck professor Julie Andersen told the crowd. "The key thing is, 'Can we treat you before you actually show symptoms of the disease?'"
Andersen and Alison McCormack of the Parkinson's Institute in Sunnyvale described in detail the latest research by their organizations in the seminar, titled "Parkinson's Disease: From Bench to Bedside." The key, they said, is turning the latest research into clinical diagnosis and treatment for patients before they show prevalent symptoms such as hand tremors, rigidity and postural instability.
Andersen said there are no standard tests available to make a diagnosis in people before they show symptoms, but advances are being made. Much of the effort in that regard is focusing on bringing down costs for imaging tests such as MRIs that could help with early detection.
McCormack said her institute's research has shown a high prevalence for impaired sense of smell among those who eventually get Parkinson's but who have yet to display other signs of the disease.
Both professors said that aging and environmental factors such as exposure to pesticides remain the primary causes. There are more than 1.5 million people worldwide suffering from Parkinson's at a cost of $6 billion annually. The rate of contracting it jumps from 1 out of 100 for people over age 65 to 1 out of 30 for those over age 85.
Many attendees said they had Parkinson's and were hoping to learn more both about the causes and new treatments.
Judith Geri, 64, of Petaluma said that people who don't yet have Parkinson's are less likely to attend a seminar on the disease. "But most of the research we heard about today is for people that don't have Parkinson's yet," she said. "All of the new tests are for people who just started showing symptoms. What are they going to do for the people who already have it?"
Recent NewsSep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement